Brian Lipton is a Senior Partner at Innovation Platform Capital, where he supports healthcare platform development, business strategy, and cross-border partnerships across the firm’s life sciences investments.

He brings over 20 years of entrepreneurial experience and more than a decade in the pharmaceutical sector. He serves as President of Gyma Laboratories of America Inc., a long-established pharmaceutical platform with over 70 years of operating history, where he has led the development of strategic partnerships and global drug development initiatives.

His experience spans the full lifecycle of pharmaceutical development, from early-stage formulation through to commercialization, as well as finance, marketing, and business development within regulated healthcare markets.

At iPC, he contributes to the advancement of healthcare platforms, including GenZen, supporting the development and scaling of high-impact therapeutic solutions.